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Abstract
The eri-1 gene encodes a 39 exonuclease that can negatively regulate RNA interference via siRNase activity. High-dose
siRNAs (hd-siRNAs) can enhance Eri-1 expression, which in return degrade siRNAs and greatly reduces RNAi efficiency. Here
we report that hd-siRNAs induce mouse Eri-1 (meri-1) expression through the recruitment of Sp1, Ets-1, and STAT3 to the
meri-1 promoter and the formation of an Sp1-Ets-1-STAT3 complex. In addition, hd-siRNAs also abolish the 39 untranslated
region (UTR) mediated posttranscriptional repression of meri-1. Our findings demonstrate the molecular mechanism
underlying the upregulation of meri-1 by hd-siRNA.
Citation: Bian Y, Zhou W, Zhao Y, Li X, Geng W, et al. (2011) High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels. PLoS
ONE 6(10): e26466. doi:10.1371/journal.pone.0026466
Editor: Chad Creighton, Baylor College of Medicine, United States of America
Received June 28, 2011; Accepted September 27, 2011; Published October 19, 2011
Copyright:  2011 Bian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by Shanghai Leading Academic Discipline Project (Project Number: B111, http://www.shmec.gov.cn/) and NSF of China
(No. 50533010, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: whuang@fudan.edu.cn
Introduction
RNA interference (RNAi) is widely accepted as a precise and
effective method for specific gene knockdown in eukaryotes. It
has been extensively studied as a powerful tool for experimental
and therapeutic purpose. However, several unexpected effects of
RNAi compromise the efficiency and spectrum of its applications.
These effects include immune activation, unintended gene
inhibition/activation, and potential endogenous microRNAs
interference [1,2]. Further improvements in this technology
require a profound understanding of the underlying mechanisms
of these obstacles.
Even RNAi delivered with high efficiency is restricted in its
activity. Several negative regulatory mechanisms of RNAi have
been described [3,4,5]. One of the best studied is the suppression
of anti-viral RNA silencing by viral suppressor proteins (e.g., p19)
[6]. In C. elegans, several negative regulators of RNAi, including eri-
1, eri-3, eri-5 and eri-6/7, have been identified through genetic
screening [7,8,9]. Eri-1 is suggested to be an exonuclease that
inhibits RNAi by degrading the 39overhangs of siRNAs, which
may impede the assembly of siRNA into RISCs, thus undermining
the efficiency of RNAi [7]. Our previous study demonstrated that,
in mice, high doses of siRNAs were less effective than low doses of
siRNAs. Transcription of the mouse eri-1 gene (meri-1) was
upregulated by high-dose exogenous non-silencing siRNA but
not by low-dose siRNA [10], and silencing of meri-1 gene could
rescue the effectiveness of RNAi [11]. These findings suggested
that there was also negative regulation for the exogenous
introduced siRNAs and that meri-1 played an important role in
this negative regulation. However, the exact molecular mechanism
underlying the regulation is poorly understood.
Sp1 is a general transcription factor that regulates the
expression of numerous genes. Both the DNA binding ability
and the transactivational activity of Sp1 are influenced by
posttranslational modifications such as phosphorylation, glycosyl-
ation, and acetylation [12,13,14,15]. Sp1 also has multifunctional
transcriptional activities through its interaction with other
transcription factors, which is required for adaptive responses to
differentiation [16,17,18], proliferation [19], and oxidative stress
[12,20,21].
Ets-1 belongs to the Ets family that regulates gene expression in
a variety of tissues and cell types [22]. This functional versatility
emerges from their interactions with other structurally unrelated
transcription factors [23]. Indeed, combinatorial control is a
characteristic property of the Ets family members [24]. The
interaction of Ets proteins with other transcription factors,
including Sp1, may modify their DNA-binding properties in a
promoter-specific fashion [23,25].
STAT3 mediates a variety of biological events including
inflammation, cellular transformation, survival, angiogenesis, and
metastasis of cancer through collaboration with other transcription
factors, including Sp1 [26,27,28,29,30]. Various types of carcin-
ogens, radiation, viruses, growth factors, oncogenes, and inflam-
matory cytokines have been found to activate STAT3 [31].
In animals, when small double-stranded RNAs possess near-
perfect complementarity to target sequences positioned in either
coding or 39-UTR regions of mRNAs, they can direct endor-
ibonucleolytic cleavage of mRNA by Argonaute 2 (Ago2) through
an RNAi-like mechanism induced by siRNAs [32]. However,
when small double-stranded RNAs possess imperfect complemen-
tarity to the 39-UTR of target mRNAs, they exert their repressive
function by inhibiting translation initiation and/or shortening poly
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the siRNA-mediated pathway significantly overlaps and shares the
common components with the miRNA-mediated pathway
[32,33,34,35], which has well-recognized roles in gene regulation
and may affect up to 30 percent of human genes [36]. This
similarity prompted us to investigate whether hd-siRNAs also
affected meri-1 expression through interfering with the miRNA-
mediated regulation in our previous study. In the miRNA
pathway, after forming the miRNA-induced silencing complexes
(miRISCs) on target mRNA 39-UTR, the mRNA and miRISCs
containing Argonaute proteins accumulate in discrete cytoplasmic
foci known as P-bodies or GW bodies [37,38,39,40,41,42]. This
mRNA is stored or decayed in the P-bodies, resulting in
posttranscriptional repression through translational repression or
mRNA destabilization [35]. The miRNA pathway usually requires
the recognition of multiple imperfect sites by the same or several
different miRNAs and the formation of multiple miRISCs on a 39-
UTR of mRNA to get effective translational repression
[43,44,45,46]. Therefore, it is especially important for miRNA-
mediated suppression to have sufficient miRISCs components.
High-dose exogenous siRNAs may compete with endogenous
miRNAs for the limited components of miRNA pathway and
block the normal function of miRNA. In addition, miRNA-
mediated repression can be effectively reversed or prevented under
certain conditions or extracellular stimuli, which makes miRNA
regulation more dynamic [35]. The repressed mRNA can also be
released from P-bodies and recruited to polysomes to reactivate its
translation [47].
In the present study, we analyzed the promoter region of the
meri-1 gene and its interaction with Sp1/Ets-1/STAT3. In
response to the hd-siRNAs treatment, Sp1 is acetylated and binds
to the meri-1 promoter where it forms a complex with transcription
factors Ets-1 and STAT3 to promote meri-1 transcription. In
addition, hd-siRNAs also abolish the 39-UTR mediated posttran-
scriptional repression of meri-1 expression. Together, these results
provide key mechanisms to illustrate how hd-siRNAs induce
enhanced meri-1 expression, which is a critical determinant in
reducing RNAi efficiency.
Results
Characterization of the meri-1 promoter sequence that is
responsive to hd-siRNA
Our previous study has showed that I.V. injection of hd-siRNAs
upregulates the meri-1 transcription in mouse liver [10]. To
analyze the in vitro meri-1 transcription in response to hd-siRNA
treatment, we measured meri-1 mRNA level by qPCR in CHO
cells. As shown in Figure 1A, meri-1 transcription was significantly
upregulated in CHO cells treated with .0.4 mg/24-well plate of
Nc siRNA. This meri-1 transcription peaked at 12 h after Nc
siRNA transfection and gradually decreased to its basal level after
36 h (Figure 1B). Therefore, the following experiments were
carried out using 1 mg/24-well plate of Nc siRNA and data was
collected 24 h after Nc siRNA transfection.
To determine whether hd-siRNAs upregulate the meri-1
transcription through its promoter, transient transfection-based
reporter gene assays were performed in CHO cells. High-dose
siRNAs, either enzymatically synthesized or chemically synthe-
sized, induced 5–7 fold of meri-1 promoter activity when compared
with the 21-bp DNA control (Figure 1C and D). Experiments in
HEK 293 cells showed similar results (Figure 1E). These results
suggest that the 21654/+115 region of meri-1 promoter is
significantly responsive to hd-siRNA treatment, indicating novel
hd-siRNA responsive elements in this region.
To examine whether the liposome-mediated siRNA transfection
procedure is necessary for meri-1 upregulation, we first transfected
the pPeri-1(21654)-GFP reporter construct into the cells alone.
Four hours later, the medium was removed and the cells were
washed three times with fresh medium and treated with 1 mg/24-
well plate of Nc siRNA_1. Without the transfection procedure, this
direct addition of siRNA was unable to induce GFP reporter
expression (Figure 1F: I), indicating that the transfection procedure
was necessary for hd-siRNA to up-regulate meri-1 transcription.
Identification of hd-siRNA responsive elements in meri-1
promoter
We analyzed the meri-1 promoter for potential hd-siRNA
responsive elements as follows. Several GFP or SEAP reporter
constructs driven by meri-1 promoter fragments of various lengths
were made and transfected into CHO cells. Similar reporter activity
(,10% difference) upon siRNA treatment was observed for the
1.8 kb promoter (Peri-1(21654)), the 500 bp (Peri-1(2386)), and
the 200 bp fragments (Peri-1(287)) (Figure 2A: I–III; Figure 2B:
panels 1–3). However, the 140 bp fragment (Peri-1(227)) lost most
of the promoter activity (Figure 2A: IV; Figure 2B: panel 7),
indicating that 287 to 227 region contains critical elements
responsible for hd-siRNA stimulated meri-1 expression.
Scanning this region with the MAPPER program (multi-
genome analysis of positions and patterns of elements of
regulation, http://mapper.chip.org/mapper/mapper-main) [48]
revealed a potential Sp1 site (CCGCCC) at 287 to 276, a
potential NRF-1 site (TGCGCCTGCGC) at 275 to 265, a
potential Ahr-ARNT site (GCGTG) at 263 to 259, and a
potential Ets-1 site (CCGGAAGTA) at 242 to 234 (Figure 2C).
Based on this result, a series of SEAP reporter constructs carrying
meri-1 promoter with deletions in this region were constructed and
the promoter activity was analyzed. As shown in Figure 2B, two
deletions contribute to the decline of promoter activity: one from
pPeri-1(287) to pPeri-1(276) containing an Sp1 binding site and
another from pPeri-1(247) to pPeri-1(227) containing an Ets-1
binding site.
To further verify the importance of the Sp1 and Ets-1 binding
sites, another series of meri-1 promoter mutations were prepared
(Figure 2 B: panel 3–4; Figure 2 C: panels 1–6). Single Sp1 binding
site deletion (287 to 276) led to significantly decreased promoter
activity (Figure 2 B: panel 4). The promoter Peri-1(284D270–
248) (Figure 2 C: panel 4), which retained both Sp1 and Ets-1
binding sites, showed almost the same promoter activity as that of
pPeri-1(287). In comparison, the promoter Peri-1(284D270–
230) (Figure 2 C: panel 5), which deleted the Ets-1 binding site,
exhibited dramatically decreased promoter activity. Mutation of
the potential Ets-1 binding site in pPeri-1(267)-SEAP, from
CCGGAAGTA to CCGGAACAA (Figure 2 C: panel 3) result in
a subsequent decreased promoter activity comparable to that of
pPeri-1(227)-SEAP construct (Figure 2 C: panel 6). In addition,
deletion of the Sp1 binding site led to not only a significant
decrease in the promoter activity, but also a loss of the ability to
respond to hd-siRNA treatment, although limited transcriptional
activity was retained in this case (Figure 2C: panels 7 and 8).
Altogether, these results indicate that both Sp1 and Ets-1 binding
sites are involved in the hd-siRNA stimulated meri-1 transcription
and may play different roles.
Involvement of Sp1 and Ets-1 in the hd-siRNA-stimulated
meri-1 promoter activity
To examine the roles of Sp1 and Ets-1 in the hd-siRNA-
stimulated meri-1 promoter activity, specific siRNAs were prepared
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transfect CHO cells together with hd-siRNAs and pPeri-1(287)-
SEAP reporter plasmid. SEAP assays revealed that the knockdown
of Sp1 and Ets-1 significantly decreased meri-1 promoter activity
(Figure 3A). These results suggest that Sp1 and Ets-1 are involved
in the regulation of hd-siRNA-stimulated meri-1 promoter activity.
To confirm the roles of Sp1 and Ets-1 in the hd-siRNA-
stimulated meri-1 promoter activity, the dominant-negative mutant
of Sp1 and Ets-1 expression vectors, pCMV-HA-Sp1 (DN) lacking
the transactivation domain of Sp1 [49] and pCMV-HA-Ets-1
(DN) lacking the transcription activation domain [50], were
constructed. CHO cells were co-transfected with pPeri-1(287)-
SEAP and Nc siRNA plus pCMV-HA, pCMV-HA-Sp1 (DN) or
pCMV-HA-Ets-1 (DN). Expression of the Sp1 dominant-negative
mutant led to an ,40% decrease in SEAP activity (Figure 3B:
panel 2). Similarly, the expression of the Ets-1 dominant-negative
mutant also led to an ,50% decrease in SEAP activity (Figure 3B:
panel 3). These experiments provide further evidence supporting
the key roles of Sp1 and Ets-1 in hd-siRNA-stimulated meri-1
promoter activity.
Sp1 and Ets-1 bind specifically to the meri-1 promoter
To determine whether Sp1 and Ets-1 bind specifically to their
binding motifs (the boxes in Figure 2C) in the meri-1 promoter,
competition EMSAs were carried out. The EMSA results
(Figure 3C and D) showed that the biotin-labeled oligonucleotides
coding for the Sp1 and Ets-1 binding motifs formed DNA-protein
complexes with nuclear proteins. In addition, pretreatment with
excess unlabelled oligonucleotides abolished the binding of nuclear
proteins to the biotin-labeled oligonucleotides, whereas the
addition of excess unlabeled mutant oligonucleotides did not show
any obvious effects. To further confirm that Sp1 and Ets-1 bind to
the putative Sp1 and Ets-1 motifs after siRNAs treatment,
immunodepletion EMSAs were performed using anti-Sp1 or
anti-Ets-1 antibody. The intensity of the retarded bands was
decreased (immunodepletion) by anti-Sp1 antibody and anti-Ets-1
antibody (Figure 3C and D). These results indicate that Sp1 and
Ets-1 can bind specifically to their respective binding motifs.
To further confirm the binding characteristics of Sp1 and Ets-1
with the meri-1 promoter, DNA affinity precipitation assays
(DAPAs) were performed using CHO cell extracts (Figure 3E).
Figure 1. Characterization of the meri-1 promoter Sequence. (A) Upregulation of meri-1 transcription induced by hd-siRNAs in CHO cells. CHO
cells were transfected with indicated quantity of Nc siRNA_2. The meri-1 mRNA level was measured by qPCR, twelve hours after transfection. (B) Time
course of hd-siRNA-stimulated transcription of meri-1. CHO cells were transfected with Nc siRNA_2. The meri-1 mRNA level was measured by qPCR. (C)
Determination of the responsive ability of the 1.8 kb meri-1 promoter, Peri-1(21654), to hd-siRNAs. CHO cells were co-transfected with GFP reporter
construct containing the 1.8 kb meri-1 promoter and Nc siRNA_1 (siHBVP) (II), or 21-bp DNA control (I). (D) Response of the meri-1 promoter to
enzymatically synthesized siRNA (Nc siRNA_1) and chemically synthesized siRNA (Nc siRNA_2). CHO cells were co-transfected with SEAP reporter
construct containing the 1.8 kb meri-1 promoter and Nc siRNA_1 (panel 1), Nc siRNA_2 (panel 2), or the 21-bp DNA control (panel 3). (E) Response of
the meri-1 promoter to hd-siRNA in the HEK 293 cells. (F) The necessity of liposome-mediated transfection process for the hd-siRNA-stimulated meri-1
promoter activity. CHO cells were transfected with GFP reporter construct containing the 1.8 kb meri-1 promoter. Four hours later, the medium was
removed and the cells were washed three times by fresh medium. Then, Nc siRNA_1 was added to the medium without transfection agent (I). CHO
cells were co-transfected with GFP reporter construct containing the 1.8 kb meri-1 promoter and Nc siRNA_1 was used as a control (II).
doi:10.1371/journal.pone.0026466.g001
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complex comprising Peri-1(287), Sp1 and Ets-1 formed. Few Sp1
bound to the Peri-1(288–230) oligonucleotides when no siRNA
induction was performed. However, the binding of Ets-1 to the
Peri-1(288–230) oligonucleotides was siRNA-treatment-indepen-
dent. In addition, cell extracts from hd-siRNAs-treated CHO cells
also demonstrated the formation of a complex comprising the Peri-
1(299–264) oligonucleotides, Sp1 and Ets-1, as well as the
formation of a complex comprising the Peri-1(257–222)
oligonucleotides, Ets-1 and Sp1. These results suggest that the
hd-siRNA treatment leads to the complex formation of Sp1 with
Ets-1 on promoter Peri-1 (287).
Furthermore, ChIP assays were performed to examine these
results in vivo. In agreement with the results of EMSAs and DAPAs,
Sp1 binding to the meri-1 promoter was significantly enhanced by
hd-siRNA treatment, whereas Ets-1 binding was not changed
(Figure 3F: II and III).
Necessity of the acetylation of Sp1 in the hd-siRNA-
stimulated meri-1 promoter activity
Several studies have shown that Sp1 is acetylated to regulate its
DNA binding affinity or transactivation [12,51,52,53]. In neurons,
Sp1 can be acetylated in response to oxidative stress and TSA-
induced Sp1 acetylation correlated with an increase in Sp1 DNA
binding [12]. To further elucidate the mechanism details of the
transcriptional regulation of meri-1, the role of Sp1 acetylation in
regulating the meri-1 promoter activity was examined. CHO cells
were treated with the prototypic histone deacetylase (HDAC)
inhibitor TSA [54,55], which is an organic hydroxamic acid that
can potently inhibit the zinc hydrolase activity of HDACs by
chelating zinc [56]. TSA concentration-dependently increased
SEAP activity in the CHO cells transfected with hd-siRNA
(Figure 4A). Since TSA might also inhibit the deacetylation of
proteins other than Sp1, an Sp1 mutant expression vector,
pCMV-HA-mSp1
K703A, was constructed. It carries a mutation at
lysine residue 703 of Sp1 that resides in the DNA binding domain
and is the only known acetylated residue of Sp1 [52]. The
overexpression of Sp1
K703A suppressed the transcriptional activity
of meri-1 promoter (Figure 4B). To further determine the role of
Sp1 acetylation in the siRNA-stimulated meri-1 promoter activity,
the acetylation of Sp1 was assessed in hd-siRNA transfected cells.
CHO cells were transfected with hd-siRNA and FLAG-Sp1
expression construct. The cell extracts were immunoprecipitated
with M2-anti-FLAG antibody-agarose beads, and the immuno-
precipitated pellets were blotted with anti-acetyl-lysine and anti-
FLAG antibodies. As shown in Figure 4C, the acetylation of Sp1
in hd-siRNA treated cells was significantly increased compared to
the control transfected cells. Next, the influence of Sp1 K703
acetylation on the recruitment of Sp1 to the meri-1 promoter was
investigated using cell extracts from the hd-siRNA-treated CHO
cells. By DAPAs, as shown in Figure 4D, the mutation of the
acetylated residue reduced the binding of Sp1 to the Peri-1(288–
230) oligonucleotides. This data suggests that the acetylation of
Sp1 K703 is critical for the recruitment of Sp1 to the promoter of
meri-1 induced by hd-siRNA and that the acetylation of Sp1 is
required for its ability to regulate the meri-1 promoter activity.
The function of STAT3 as a bridge between Sp1 and Ets-1
in the hd-siRNA-stimulated meri-1 promoter activity
Because overexpression of Sp1, Ets-1 or Sp1 and Ets-1 could
only increase meri-1 transcription very slightly (Figure 5A: panels
2–4) , the later studies, which have shown that siRNAs can activate
innate immunity in mammalian cells [57,58,59,60,61], prompted
us to examine the involvement of inflammation-related transcrip-
tion factors in the regulation of the hd-siRNA-stimulated meri-
1expression. Through screening by RNAi, we found that the
STAT3 knockdown significantly decreased the meri-1 promoter
activity (Figure 5B: panel 2 and 3), while the overexpression of
STAT3 significantly increased the meri-1 promoter activity
(Figure 5A: panel 5). Co-expression of Sp1, Ets-1 and STAT3
increased the meri-1 promoter activity to a higher level than Sp1
and/or Ets-1 alone (Figure 5A: panel 6), suggesting that STAT3 is
essential for the siRNA-stimulated meri-1 promoter activity.
To determine if STAT3 is directly involved in the regulation of
meri-1 promoter activity, DAPAs were performed using CHO cell
extracts (Figure 5C). Only when CHO cells were treated with hd-
siRNAs (siRNA_1 or siRNA_2) was the existence of STAT3
observed in the complex formed on the Peri-1(299–264)
oligonucleotides, which contain the Sp1 binding site only. If no
siRNA induction was performed, no STAT3 in the complex
formed on the Peri-1(299–264) oligonucleotides. Although the
recruitment of STAT3 to the Peri-1(257–222) oligonucleotides
(Ets-1 binding site only) is siRNA-treatment-independent, the
recruitment of STAT3 to the Peri-1(288–230) oligonucleotides,
which includes both the Sp1 binding site and the Ets-1 binding
site, was significantly increased by siRNA treatment. In the ChIP
assays, the recruitment of STAT3 to the meri-1 promoter was
enhanced by hd-siRNA treatment (Figure 3F: IV).
In order to examine the role of STAT3 in regulating the meri-1
promoter, Sp1 and Ets-1 expression vectors were co-transfected
with various STAT3 mutant expression vectors, including
STAT3b, STAT3 (Y705F), STAT3D and STAT3DN (162–770).
STAT3b retains the tyrosine residue at position 705 critical for
dimerization but lacks a serine residue at position 727 which is a
phosphorylation site [62]. STAT3 (Y705F) carries phenylalanine
substitution at Tyr705 [63]. STAT3D contains mutations at
positions important for DNA binding [63]. STAT3DN (162–770)
lacks the N-terminal residues from position 1 to 161, which were
Figure 2. Sp1 and Ets-1 binding sites are the key cis-elements for the siRNA-stimulated meri-1 promoter activity. The hd-siRNA-
stimulated transcriptional activity of the truncated meri-1 promoters was determined using the GFP reporter assay and the secreted alkaline
phosphatase (SEAP) activity assay. (A) GFP assay testing the activity of the truncated meri-1 promoters. CHO cells were co-transfected with Nc
siRNA_1 and GFP reporter constructs containing the truncated meri-1 promoters (I–VI). (B) SEAP activity assay testing the activity of the truncated
meri-1 promoters. CHO cells were co-transfected with SEAP reporter constructs containing the truncated meri-1 promoters and Nc siRNA_1. (C) Upper
panels: A schematic presentation of the putative trans-factor binding sites in the 287 to 228 region of the meri-1 promoter, as predicted by MAPPER
[48]. Middle panels: The SEAP activity in the culture media of the CHO cells co-transfected with Nc siRNA_1 and the SEAP reporter constructs,
including the 180-bp meri-1 promoter (Peri-1(287)) (panel 1), the 160-bp meri-1 promoter with deletions of Sp1 and NRF-1 site (Peri-1(267)) (panel 2),
the same fragment with a mutation in the Ets-1 binding site (Peri-1(267)mEts-1) (panel 3), the same sequence as Peri-1(247) but with the Sp1 site
added to the 59 end (Peri-1(284D270–248)) (panel 4), the same sequence as Peri-1(227) but with the Sp1 site added at the 59 end (Peri-
1(284D270–230)) (panel 5), or the 120-bp meri-1 promoter (Peri-1(227)) (panel 6). Lower panel: The SEAP activity in the culture media of the CHO
cells transfected with the truncated meri-1 promoters. The CHO cells were co-transfected with SEAP reporter constructs containing the truncated
meri-1 promoters and Nc siRNA_1 or 21-bp DNA control. The data represents the mean of three independent experiments, and the error bars indicate
the SD of triplicate samples.
doi:10.1371/journal.pone.0026466.g002
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[29,64]. Only the N-terminal deletion mutant affected the activity
of STAT3 in the hd-siRNA-stimulated meri-1 promoter activity
(Figure 5A: panels 7–10). These results suggest that STAT3 might
function as a part of the complex regulating the meri-1 promoter
without binding to the DNA. To further confirm this presumption,
DAPAs were performed. As shown in Figure 5D, when Sp1 and
Ets-1 were knocked down by RNAi, the presence of STAT3 in the
complex formed on the Peri-1(288–230) oligonucleotides was
reduced. Furthermore, when STAT3 was knocked down by
RNAi, fewer Ets-1 proteins were co-immunoprecipitated with Sp1
(Figure 5F), indicating that STAT3 is a determinant of hd-siRNA-
stimulated Sp1 and Ets-1 complex formation. These results suggest
that STAT3 might function as an adapter protein bridging Sp1
with Ets-1 and enhancing the formation of the pre-initiation
complex to activate transcription of meri-1 gene.
Involvement of the 39-UTR in the upregulation of meri-1
expression stimulated by hd-siRNA
To examine whether the 39-UTR participates in the regulation of
meri-1 expression, equal molar amounts of the reporter plasmid,
pSEAP-meri-1_39-UTR (0.3 mg/24-well plate), and control plasmid,
pSEAP2-control (0.17 mg/24-well plate), were transfected into
CHO cells. As shown in Figure 6A, the expression of SEAP was
significantly repressed by the 39-UTR of meri-1. This indicates that
the 39-UTR of meri-1 mediates the gene repression. There were no
differences in the quantity of SEAP mRNA from constructs with or
without the meri-1 39-UTR as assessed by qPCR (Figure 6 B). This
Figure 3. Involvement of Sp1 and Ets-1 in the siRNA-stimulated meri-1 Promoter Activity. (A) Knockdown of Sp1 and Ets-1 genes inhibits
the siRNA-stimulated meri-1 promoter activity. A: The SEAP activity in the culture media of the CHO cells co-transfected with pPeri-1(287)-SEAP and
Nc siRNA plus siSp1_1, siSp1_2, siEts-1_1 or siEts-1_2 was measured. The knockdown effects were shown in lower panel. (B) Overexpression of the
Sp1 and Ets-1 dominant-negative mutant inhibits the siRNA-stimulated meri-1 promoter activity. The SEAP activity in the culture media of the CHO
cells co-transfected with pPeri-1(287)-SEAP and Nc siRNA plus pCMV-HA, pCMV-HA-Sp1(DN) or pCMV-HA-Ets-1(DN) was measured. The data
represents the mean of three independent experiments, and the error bars indicate the SD of triplicate samples. (C)–(F) Sp1 and Ets-1 binding
specifically to the meri-1 promoter. (C) and (D) EMSAs were performed using various biotin-labeled oligonucleotides corresponding to the putative
Sp1 and Ets-1 elements in the meri-1 promoter, as described in Table 1. Nuclear extracts were prepared from CHO cells pre-treated with Nc siRNA_1.
The competition assays were performed with or without a 50-fold excess of each unlabelled oligonucleotide, as indicated above each lane.
Immunodepletion EMSAs were performed using 1 ml of the anti-Sp1, anti-Ets-1 antibodies and control normal mouse IgG, as indicated above each
lane. Immunodepletion effects were shown under the related lanes. (E) Cell extracts of the CHO cells pre-treated with or not with Nc siRNA were
prepared. The aliquots were subjected to DNA affinity precipitation assay (DAPA) with biotinylated oligonucleotides that contained the Sp1-, Ets-1- or
both Sp1- and Ets-1-binding sites in the meri-1 promoter (see Table 1). The precipitated complexes (Precipitation) were immunoblotted with anti-Sp1
or anti-Ets-1 antibodies, and the whole cell lysates (WCL) were monitored for the expression of Sp1 or Ets-1. The relative intensity of bands was
quantified using the ImageGouge software (Fuji). (F) CHO cells treated with or not with hd-siRNAs were harvested for chromatin immunoprecipitation
(ChIP) assays. Chromatin suspensions were immunoprecipitated with the indicated antibodies and control IgG. The resulting precipitants were
subjected to PCR to amplify the region as indicated in the upper panel. The amplified products were visualized by ethidium bromide staining after
gel electrophoresis. Representative data of 30 cycles are shown.
doi:10.1371/journal.pone.0026466.g003
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expression repression manner rather than an mRNA destabilization
manner. To determine whether hd-siRNAs affected this repression,
CHO cells were cotransfected with 0.3 mg of pSEAP-meri-1_39-
UTR and increasing doses of Nc siRNA_2.Repressionwas reduced
by Nc siRNA in a dosage-dependent manner until a limit at
approximately 0.6 mg/24-well plate (Figure 6C). The mRNA level
of SEAP-meri-1_39-UTR was unchanged by hd-siRNA treatment,
as assessed by qPCR assay (Figure 6D), suggesting that the effect of
hd-siRNA occurs at the posttranscription level. To elucidate more
details of this process, we transfected a linear increasing dose of
pSEAP-meri-1_39-UTR with or without 0.6 mg Nc siRNA. As
shown in Figure 6E, the increase of SEAP expression was not
proportional to the dose of reporter plasmid (Figure 6E: line 1). A
threshold of the repression effect, at about 0.4 mg/24-well plate of
pSEAP-meri-1_39-UTR, appeared, below which the expression of
SEAP was repressed. However, with hd-siRNA treatment
(Figure 6E: line 2), the inflection point appeared earlier than
compared with no siRNA treatment (Figure 6E: line 1). This result
confirmed that hd-siRNA could abolish the repression of meri-1
expression exerted from its 39-UTR. Time course analysis showed
that the increase of reporter gene expression was in a time-
dependent manner until it peaked at 12 h after Nc siRNA
transfection (Figure 6F). Because the first four hours likely was the
processoftransfection,the resultsindicate thathd-siRNAexertedits
effect rapidly. These results suggested that hd-siRNA could also
abolish the posttranscription repression exerted from 39-UTR,
which further enhanced the expression of meri-1.
Figure 4. Necessity of the Sp1 acetylation in the siRNA-stimulated meri-1 Promoter Activity. (A) The histone deacetylase (HDAC) inhibitor
TSA enhances the meri-1 promoter activity in a dosage-dependent manner. TSA was added to the culture media of the CHO cells transfected with
pPeri-1(287)-SEAP and Nc siRNA_2. (B) Mutation of the acetylation site interferes with the function of Sp1 as the activator of meri-1 promoter. The
SEAP activity in the culture media of the CHO cells co-transfected with pPeri-1(287)-SEAP and Nc siRNA_2 plus pCMV-HA, pCMV-HA-Sp1 (K703A) or
pCMV-HA-Sp1 was measured. The data represents the mean of three independent experiments, and the error bars indicate the SD of triplicate
samples. (C) The acetylation of Sp1 is enhanced by hd-siRNA. Cell extracts were prepared from the CHO cells transfected with pCMV-FLAG-Sp1 or co-
transfected with pCMV-FLAG-Sp1 and Nc siRNA_2. Immunoprecipitation was performed using M2-anti-FLAG antibody-agarose beads. The
immunoprecipitated pellets were analyzed by immunoblotting with anti-acetyl-lysine (upper panel) and anti-FLAG (lower panel) antibodies. The
relative intensity of bands was quantified using the ImageGouge software. (D) Acetylation is necessary for the recruitment of Sp1 to the meri-1
promoter. Cell extracts of the CHO cells transfected with pCMV-FLAG-Sp1 or co-transfected with pCMV-FLAG-Sp1 and Nc siRNA_2, or with pCMV-
FLAG-Sp1 (K703A) and Nc siRNA_2 were prepared. The aliquots were subjected to DAPA with biotinylated Peri-1(288–230) oligonucleotides that
contain the hd-siRNA elements in the meri-1 promoter (see Table 1). The precipitated complexes (Precipitation) were immunoblotted with anti-FLAG
and acetyl-lysine antibodies, and the whole cell lysates (WCL) were monitored for the expression of FLAG-Sp1 or FLAG-Sp1 (K703A). The relative
intensity of bands was quantified using the ImageGouge software.
doi:10.1371/journal.pone.0026466.g004
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This study elucidated that the proximal promoter of meri-1
contains potential hd-siRNA responsive elements and that
acetylated Sp1, Ets-1 and STAT3 participate in the transcription
of meri-1. Based on our results, we propose that, in response to
treatment with hd-siRNA, Sp1, STAT 3 and Ets-1 form a
complex on the meri-1 promoter to elevate the level of meri-1
transcription. Notably, these trans-acting factors play different roles
in the regulation of meri-1 transcription. Sp1 and STAT3 are
responsible for the enhancement of meri-1 transcription in response
to hd-siRNA treatment, whereas Ets-1 is likely to participate in
both the induced expression and constitutive expression of meri-1.
The constitutive expression of Eri-1 has been reported in the
nematode worm and in humans [7,65]. In the nematode worm,
Eri-1 is generally expressed at low levels [7]. Consistent with these
reports, we found that the meri-1 gene was still expressed at a low
level without the hd-siRNA treatment. Our results suggest that
Ets-1 may be involved in this constitutive expression.
It is now widely recognized that acetylation is a crucial
posttranslational modification for regulation of Sp1 activity. Many
findings indicated that acetylation may increase Sp1-mediated
transcription [66]. The only acetylation site of Sp1 is located in the
DNA binding domain [52], which suggests that acetylation of Sp1
may affect its DNA binding and/or gene transactivation functions.
Previous studies reported that Sp1 was acetylated by the
Figure 6. 39-UTR involved in the upregulation of meri-1 expression stimulated by hd-siRNA. (A) 39-UTR of meri-1 functions in the
regulation of meri-1 expression. The SEAP activity in the culture media of the CHO cells transfected with SEAP constitutive expression construct,
pSEAP2-control, or with SEAP reporter construct containing the 3.9 kb meri-1 39-UTR was measured. (B) Quantity of SEAP mRNA unaffected by meri-1
39-UTR. The SEAP mRNA level was measured by qPCR. (C) Nc siRNAs reduced the meri-1 39-UTR-mediated repression in a dosage-dependent manner.
The SEAP activity in the culture media of the CHO cells co-transfected with pSEAP-meri-1_39-UTR and an increasing dose of Nc siRNA_2 was
measured. (D) Quantity of SEAP-meri-1_39-UTR mRNA unaffected by hd-siRNA treatment. The SEAP-meri-1_39-UTR mRNA level was measured by
qPCR. (E) Abolishment of the meri-1 39-UTR-mediated repression by hd-siRNA treatment. The SEAP activity in the culture media of the CHO cells that
were transfected with an increasing dose of pSEAP-meri-1_39-UTR plus Nc siRNA_2 (line2) or not plus Nc siRNA_2 (line1) was measured. (F) Time
course of the abolishment of the meri-1 39-UTR-mediated repression by hd-siRNA treatment. The SEAP activity in the culture media of the CHO cells
transfected with pSEAP-meri-1_39-UTR plus Nc siRNA_2 or not plus Nc siRNA_2 was measured at the indicated hours after transfection.
doi:10.1371/journal.pone.0026466.g006
Figure 5. STAT3 bridges Sp1 and Ets-1 in the siRNA-stimulated meri-1 Promoter Activity. (A) The siRNA-stimulated meri-1 promoter
activity is further enhanced by overexpression of STAT3. By using various STAT3 mutants, the involvement of STAT3 was examined. The SEAP activity
in the culture media of the CHO cells co-transfected with pPeri-1(287)-SEAP and Nc siRNA_2 plus the indicating plasmids expressing Sp1, Ets-1,
STAT3 and various STAT3 mutants. (B) Knockdown of STAT3 inhibits the siRNA-stimulated meri-1 promoter activity. The SEAP activity in the culture
media of the CHO cells co-transfected with pPeri-1(287)-SEAP and Nc siRNA plus siSTAT3_1 or siSTAT3_2 was measured. (C) STAT3 is recruited to the
meri-1 promoter by hd-siRNA induction. Cell extracts of the CHO cells transfected with or without hd-siRNA were prepared. The aliquots were
subjected to DAPA with biotinylated oligonucleotides that contained the Sp1-, Ets-1- or both Sp1- and Ets-1-binding sites in the meri-1 promoter (see
Table 1). The precipitated complexes (Precipitation) were immunoblotted with anti-STAT3 antibody, and the whole cell lysates (WCL) were monitored
for the expression of STAT3. The relative intensity of bands was quantified using the ImageGouge software. (D) STAT3 functions in the meri-1
promoter activity without DNA binding. Cell extracts of the CHO cells transfected with Nc siRNA_2, or with Nc siRNA_2 plus siSp1_2 and siEts-1_2
were prepared. The aliquots were subjected to DAPA with biotinylated Peri-1(288–230) oligonucleotides that contain the hd-siRNA elements in
meri-1 promoter (see Table 1). (E) STAT3 functions as a bridge of Sp1 and Ets-1 in the hd-siRNA-stimulated meri-1 promoter activity. Cell extracts were
prepared from the CHO cells co-transfected with pCMV-FLAG-Sp1 and Nc siRNA_2 plus siSTAT3_2 or not. Immunoprecipitation was performed using
M2-anti-FLAG antibody-agarose beads. The immunoprecipitated pellets were analyzed by immunoblotting with anti-Ets-1 antibody. The relative
intensity of bands was quantified using the ImageGouge software.
doi:10.1371/journal.pone.0026466.g005
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histone acetyltransferase (HAT) region of p300 and the DNA-
binding domain (DBD) of Sp1 stimulated the DNA-binding
activity of Sp1 [52,67]. In our study, we found that Sp1 acetylation
coincided with the increased affinity of Sp1 for DNA binding.
However, the functional relevance of this post-translational
modification in the DNA binding activity of Sp1 is disputed.
Contradictory results were reported from other groups adopting
different systems for study. Schnur et al. found that inhibition of
HDACs increases 5-LO gene expression via enhanced Sp1/Sp3
binding to the 5-LO promoter [68]. A similar result was found in
HDAC inhibitor-induced CD20 gene transactivation, in that
promoter acetylation coincided with the enhanced binding of Sp1
[69]. In another study, TSA induced transforming growth factor b
type II receptor (TbRII) promoter activity and acetylation of Sp1
by recruitment of HATs to the Sp1?NF-Y complex, whereas, Sp1
binding to the TbRII promoter was not changed [53]. Conversely,
Waby et al. showed that acetylated Sp1 loses p21- and bak-
promoter-binding function in vitro, allowing access to the promoter
region by Sp3 to drive transcription in a colon cell line [15]. In the
present study, the interaction of Sp1 with the meri-1 promoter was
shown to be enhanced by hd-siRNAs treatment via several
independent lines of evidence. The EMSAs, DAPAs and ChIP
assays demonstrated that Sp1 interacted with meri-1 promoter after
cells were treated with hd-siRNAs. We also first examined the
DNA binding activity of mutant Sp1 (K703A) by DAPA. Results
showed that the recruitment of Sp1 to the meri-1 promoter was
attenuated when the lysine-703 was substituted by alanine.
Meanwhile, the overexpression of mutant Sp1 (K703A) signifi-
cantly repressed reporter gene expression in CHO cells. This
evidence indicates that the acetylation is critical for meri-1
expression induced by hd-siRNAs. Based on the results presented
in the current studies, potential roles of acetylation in regulating
Sp1 DNA binding activity may be proposed. One possibility is that
the acetylation is a prerequisite for Sp1 binding to the meri-1
promoter, which may modify its biological activity including
altering protein-protein interactions, DNA recognition, or/and
protein stability. Acetylation might induce a conformational
change in the DBD of Sp1 resulting in an increase in its affinity
for DNA binding or selecting the partner proteins interacting with
Sp1 which may further enhance the transcriptional competence of
Sp1 and the stability of transcriptional complex. The second
possibility is that the acetylation is just a concomitant consequence
of Sp1 recruiting HAT to the meri-1 promoter to activate the gene
expression. It has been reported that the HAT region of p300
interacts with the DBD of Sp1 to stimulate Sp1 DNA binding
activity by physical interaction rather than acetylation, despite Sp1
being acetylated by the p300 acetyltransferase region. Once Sp1 is
acetylated and binds to DNA, the affinity for p300 and Sp1 was
reduced [52,67]. In our study, we found that the mutation of
acetylation site compromised the binding of Sp1 to DNA. For
mutant Sp1 (K703A), which cannot be acetylated, the DBD of Sp1
is continuously occupied by p300 HAT domain, which may
hinder Sp1 from binding to DNA. This conclusion was supported
by Hung et al. reported data that p300 interacted with mutant Sp1
(K703A) more than with wild-type Sp1 [52].
In this study, we found that the transactivational activity of
STAT3 was independent of the phosphorylation and DNA
binding activity in the hd-siRNA-stimulated meri-1 promoter
activity. This finding is distinct from the classical concept that
STAT3 should bind to its own consensus DNA element. Similar to
this finding, STAT3 also participated in the regulation of DINE
(Damageinduced neuronal endopeptidase) without phosphoryla-
tion and DNA binding [29]. Our study further confirmed the role
of STAT3 function as a necessary component of the pre-initiation
complex to bridge other transcriptional components in response to
stimuli. It will be of great interest to see if this molecular
mechanism may be a general phenomenon in many other
STAT3-regulated gene transcription systems. More evidence
suggests that coactivation is an important and general mechanism
in transcriptional regulation. The interaction between different
trans-acting factors could give them functional versatility and
ensure the cells’ proper response to redundant stimuli by
integrating multiple signals. Trans-acting factors activated by
different pathways construct a gene-specific architecture of the
transcription complex to mediate the selective control of
transcriptional activity. The present study revealed that there
was a function synergy of different trans-acting factors in the
complex. In addition to STAT3 functioning as a bridge, Sp1
might function as a recruiter or scaffold for other transcription
factors in the complex. Consistently, some studies have revealed
that STAT3 or c-Jun can activate the promoters without their
binding sites, through the interaction with Sp1 [27,28,29,70,71].
Meanwhile, Sp1 could also recruit HATs and HDACs to the
promoter region to modulate transcription by directly acetylating/
deacetylating the transcription factors and associated cofactors
[52,68]. Our result showed that, in the case of hd-siRNA-
stimulated meri-1 promoter activity, the acetylation of Sp1 was
enhanced by Nc siRNA treatment, which suggested that the
overall acetylation status of the meri-1 promoter, which is
maintained through a balance of HAT and HDAC activities, is
pro-acetylation. It has been reported that the NH2-terminal
acetylation of STAT3 is necessary for IL-6-dependent gene
transcription and the decrease of HDAC1 reduced the nuclear
export of STAT3, leading to nuclear accumulation of acetyl
STAT3 and enhanced target gene transcription [72]. In our study,
we also observed that the binding of HDAC1 to the meri-1
promoter was impeded by hd-siRNA treatment (data not shown)
and that NH2-terminal deletion of STAT3 suppressed the meri-1
promoter activity. Together, we conclude that Sp1 regulates meri-1
promoter activity not only by its transcriptional activity, but also
regulating the steady state level of HATs and HDACs to control
the reversible acetylation of the non-histone protein STAT3.
Consequently, the subcellular distribution and nucleocytoplasmic
shuttling of STAT3 dictated the duration and degree of gene
activation in response to hd-siRNA.
In conclusion, as shown in Figure 7, we propose that, in
response to hd-siRNA treatment, Sp1 interacts with histone
acetyltransferases (HAT) leading to the acetylation of Sp1 and the
DNA binding of Sp1 to the meri-1 promoter. This occurs in
conjunction with release of HDACs from the promoter. Then,
STAT3 is recruited to the meri-1 promoter and bridges Sp1 with
the co-activator Ets-1 to form the transcriptional complex and
elevate the level of gene transcription.
We have begun to realize the important role of the 39-UTR of
mRNA, with miRNA activity playing a major role in gene
regulation [35]. In human, up to 30 percent of genes may be
regulated by this mechanism [36]. In our study, we found that the
meri-1 gene is regulated by a 39-UTR-mediated posttranscriptional
repression. The expression of the reporter gene was repressed
when the 39-UTR of meri-1 was downstream of the reporter gene.
Moreover, the increase of reporter gene expression was not
proportional with the dose of reporter gene transfected. When the
amount of reporter vector was lower than 0.4 mg per 24-well plate,
the expression of reporter gene was almost completely repressed. A
significantly dosage-responsive increase emerged when the amount
of reporter vector transfected was over 0.4 mg per 24-well plate.
This threshold of the repression effect indicates that the amount of
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miRNA and siRNA pathways share common components [35],
we reasoned that high-dose exogenous siRNAs may compete with
endogenous miRNAs for the limited components of miRNA
pathway and block the normal function of miRNA. Consistent
with this hypothesis is our finding that the repression of the
reporter gene was abolished by Nc siRNAs in a dosage-dependent
manner. In addition, in our experiments, similar results were
observed when different Nc siRNAs were used (data not shown),
suggesting that the meri-1 39-UTR-mediated expression repression
could be abolished by hd-siRNA in a sequence-independent
manner. However, although the abolishment of the repression
occurred rapidly after siRNA treatment and the effect of hd-
siRNAs is sequence-independent, it couldn’t exclude the possibility
that hd-siRNAs decrease the expression of miRNAs which
regulate the expression of meri-1. More details of the mechanism
under hd-siRNA abolishing the 39-UTR- mediated repression of
meri-1 wait to be elucidated in further studies.
RNAi is a powerful research tool, and the clinical potential of
RNAi as therapeutics has been demonstrated. Some studies have
demonstrated clearly that the efficacy of RNAi is based on
multiple factors. Some key mechanistic aspects need to be
investigated before RNAi becomes a real therapeutic modality.
The amount of siRNA used is a crucial factor, as the use of non-
optimal siRNA minimizes the knockdown effect [10,11,73,74].
Persengiev et al. [57] have shown that over 1000 genes involved in
diverse cellular functions were affected by conventional siRNAs in
a concentration-dependent manner. Our present and previous
studies indicated that, in addition to the stimulation of the
mammalian innate immune response, hd-siRNAs also induced a
feedback mechanism of RNAi leading to the negative regulation of
RNAi efficiency [10,11,74]. These results caution against the
application of hd-siRNA. In cases where high-dose application is
necessary, especially when systemically administering combined
siRNAs to multiple targets, we should inhibit the efficiency of Eri-1
to obtain an expected efficiency. The present study has provided
information elemental and necessary for RNAi application.
Materials and Methods
Plasmids
The meri-1 promoter fragments of various lengths were
generated by PCR amplification from the genomic DNA of
C57BL/6 mice, using primer P+115 (59-cGAATTCGCCGCC-
TCTCGCGGGCCGCGAGAC-39) as the antisense primer and
the following primers as the sense primers, including P21654 (59-
cgAGATCTCGGGATCCATTAATGGGCTGGTG-39), P2386
(59-cgAGATCTATTAATGGAATCTAGACCCTAGGAACG-
C-39), P287 (59-cgAGATCTATTAATGGACCCGCCCACTG-
CGCCTGC-39), P276 (59-cgAGATCTCTGCGCCTGCGCG-
GCGTGACAAC-39), P267 (59-cgAGATCTCGCGGCGTGA-
CAACGCCACAC-39), P247 (59-cgAGATCTCGCTCCCGGA-
AGTAGGAGGC-39), P227 (59-cgAGATCTATTAATGTCC-
GACGGAGTTTGTGTGG-39), P27( 5 9-cgAGATCTATTAA-
TCGGCCGCCGCGGGAACGTG-39), P+16 (59-cgAGATC-
TATTAATCGCGGTAGTTTTTCAAGGGAG-39), P284D2
70–248 (59-cgAGATCTCCCGCCCACTGCGCCGCTCCCG-
GAAGTAGGAGGCG-39), and P284D270–230 (59-cgA-
GATCTCCCGCCCACTGCGCGTCCGACGGAGTTTGTG-
TGGC-39). Each primer was named according to the first
nucleotide relative to the transcription start site (+1) of meri-1
gene. These fragments were cloned into the pEGFP-N2 vector
(Clontech, USA) between Ase I and EcoR I sites to replace the
CMV promoter upstream of the GFP reporter gene. Similarly,
these fragments were also cloned into the pSEAP2-control vector
(Clontech, USA) between Bgl II and EcoR I sites to replace the
SV40 early promoter upstream of the SEAP reporter gene. A
consensus binding site mutant corresponding to Ets-1 (nt 242 to
234; 59- CCGGAAGTA -39 to 59- CCGGAACAA -39) was
constructed using the QuikChange site-directed mutagenesis kit
(Stratagene, USA). The 3866 bp meri-1 39-UTR was cloned from
the genomic DNA of C57BL/6 mice and inserted into the
pSEAP2-control vector downstream of SEAP reporter gene to
produce the pSEAP-meri-1_39-UTR vector.
The cDNA fragments coding for Sp1, Ets-1, STAT3, dominant-
negative mutant of Sp1 (Sp1DN) (amino acids 592–758),
dominant-negative mutant of Ets-1 (Ets-1DN) (amino acids 306–
441), STAT3DN (amino acids 162–770), and STAT3b were PCR
amplified from their cDNAs and subcloned into the pCMV-HA
vector (Clontech, USA). STAT3D and STAT3 (Y705F) mutants
were generated by using the QuikChange II site-directed
mutagenesis kit. The Sp1 expression vector pCMV-HA-mSp1
(K703A) carrying the Sp1 mutant (K703A) was similarly
generated. All these constructs were verified by sequencing. Sp1,
mSp1 (K703A) and STAT3 were also subcloned into pCMV-
Tag2 (Stratagene, USA) to generate the N-terminal FLAG tagged
protein.
Preparation of siRNAs
Both enzymatically synthesized siRNAs and chemically synthe-
sized siRNAs were used in this study. The enzymatically
synthesized siRNAs for Sp1, Ets-1, and STAT3 were prepared
Figure 7. Schematic summary of the hd-siRNA-stimulated meri-
1 promoter activity. High-dose siRNAs treatment induces the
interaction of Sp1 with histone acetyltransferase (HAT) leading to the
acetylation of Sp1 and the DNA binding of Sp1 to the meri-1 promoter.
In addition, histone deacetylases (HDAC) are released from the
promoter. STAT3 will be recruited to the meri-1 promoter and bridge
Sp1 with the co-activator Ets-1 to form the transcriptional complex and
enhance the transcription of meri-1.
doi:10.1371/journal.pone.0026466.g007
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and siSTAT3_1. They target exons 4 and 5 of mouse Sp1 gene
(from 1801 to 2032 in mRNA sequence, NM_013672), exons 5
and 6 of mouse Ets-1 gene (from 876 to 1210 in mRNA sequence,
NM_011808), and exon 21 of mouse STAT3 (from 2168 to 2381
in mRNA sequence, NM_213660). The chemically synthesized
siRNAs include the siSp1_2 duplex 59-GGAACAGAGUGGCAA-
CAGUdTdT-39 and 59-ACUGUUGCCACUCUGUUCCdTdT-
39 [77], the siEts-1_2 duplex 59-GGACAAGCCUGUCAUUC-
CUdTdT-39 and 59-AGGAAUGACAGGCUUGUCCdTdT-39
[77], and the siSTAT3_2 duplex 59-CTTCAGACCCGCCAA-
CAAAdTdT-39 and 59- TTTGTTGGCGGGTCTGAAGdTdT -
39 [78].
The enzymatically synthesized nonsilencing control siRNA
(esiHBVP) was derived from the Hepatitis B Virus P protein and
prepared as previously described [74] and named as Nc siRNA_1.
A commonly used chemically synthesized nonsilencing control
siRNA (sense: 59-UUCUCCGAACGUGUCACGUdTdT-39, an-
ti-sense: 59-ACGUGACACGUUCGGAGAAdTdT-39) was also
used as Nc siRNA_2 [79,80,81,82,83,84,85,86,87,88]. A 21-bp
DNA control, the structure of which simulates siRNA duplex
(sense: 59-CGTACGCGGAATACTTCGATT-39, anti-sense: 59-
TCGAAGTATTCCGCGTACGTT-39), was used as a negative
control in experiments where indicated.
Cell culture and Transfection
CHO-K1 (Chinese Hamster Ovary, ATCC strain CCL 61) cells
and HEK293 (Human embryonic kidney, ATCC strain
CRL1573) cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum (Gibco, USA),
100 mg/ml streptomycin, and 100 IU/ml penicillin, at 37uC and
5% CO2. The cells were transfected at 70% confluence using
Lipofectamine 2000 (Invitrogen, USA).
Reverse transcription (RT)
Polymerase chain reaction (PCR) and quantitative real-
time PCR (qPCR) Assay. Total RNA was isolated from CHO
cells transfected with or without Nc siRNAs using a Qiagen RNA
isolation kit. First-strand cDNA was synthesized from 1 mg of total
RNA in a final volume 10 ml using ReverTra AceH qRCP RT kit
(Toyobo, Japan). The qPCR was performed using an ABI Prism
7900HT (Applied Biosystems, USA) and data were analyzed with
SDS 2.2 software (Applied Biosystems, USA). All primers were
designed using Primer3 (http://fokker.wi.mit.edu/primer3/) [89].
PCR amplifications (in triplicates) were carried out in a 10 ml
reaction volume using THUNDERBIRD
TM SYBRH Green/
ROX Realtime PCR Master Mix. The reaction conditions were as
follows: 95uC for 5 min; 40 cycles at 95uC for 15 s and 60uC for
1 min; 1 cycle at 95uC for 1 min, 55uC for 30 s and 95uC for 30 s
for the dissociation curve. The expression of meri-1 was normalized
to b-actin. Threshold cycle numbers (Ct) were determined with
SDS 2.2 software and transformed using by the DCt comparative
method. After PCR amplification, a melting curve of each
amplicon was determined to verify its accuracy.
Reporter Assay
GFP expression was detected as following. CHO cells were
transfected with the pPeri-1-GFP series of reporter vectors
together with either the Nc siRNAs or the 21-bp DNA control.
Twenty-four hours later, GFP expression was measured under a
LEICA DM RA2 microscope (objective 206) at 488 nm.
Alkaline phosphatase expression was detected as following.
CHO cells were transfected with the pPeri-1-SEAP series of
reporter constructs together with either the Nc siRNAs or the 21-
bp DNA control. Twenty-four hours later, the SEAP (secreted
alkaline phosphatase) activity of the culture media was measured
by performing a colorimetric assay as recommended [90]. Briefly,
50 ml of 4-fold diluted, heat-treated (65uC, 30 min) culture
medium was added to 150 ml of the SEAP assay solution
(20 mM para-Nitrophenylphosphate (pNPP), 1 mM MgCl2,
10 mM L-homoarginine, and 1 M diethanolamine, at pH 9.8).
The reaction was incubated at 37uC for 15 min and the
absorbance was measured at 405 nm using a microplate reader.
Parallel experiments using a SEAP constitutive expression
construct, pSEAP2-control, were performed to monitor and
normalize transfection efficiency.
Electrophoretic Mobility Shift Assays (EMSAs)
CHO cells were transfected with Nc siRNAs. Twelve hours
after transfection, the nuclear extracts of the treated cells were
prepared using the Nuclear and Cytoplasmic Protein Extraction
Kit (Beyotime).
Twenty femtomoles of 59 biotinylated double-stranded oligo-
nucleotides (Invitrogen) were added to 2 mg of the nuclear extracts
in a final volume of 10 ml that contained 0.5 mg of poly(dI-dC),
10 mM Tris-HCl (pH 7.5), 50 mM KCl, 0.5 mM DTT, 4%
glycerol, 5 mM MgCl2 and 1% NP-40. The reactions were then
incubated for 15 min at room temperature. The oligonucleotides
used for EMSAs are listed in Table 1. The samples were
electrophoresed at 8 V/cm through 6% non-denaturing poly-
acrylamide gels pre-equilibrated in 0.56TBE (45 mM Tris,
45 mM Boric Acid and 1 mM EDTA, pH 8.3). The binding
reactions were transferred to Nylon membranes and the
transferred DNA was cross-linked to the membrane using the
UV-light cross-linker. Finally, biotinylated double-stranded probes
were detected by chemiluminescence.
For the competition assay, unlabeled double-stranded oligonu-
cleotides were incubated with the nuclear extracts at 4uC for
Table 1. The oligonucleotides that were used for EMSA and Oligonucleotide Precipitation Assay.
BPeri-1 ((299)–(264)) 59- BIOTIN-AGAAAAAGGAGGGGACCCGCCCACTGCGCCTGCGCG-39
Peri-1 ((299)–(264)) 59-AGAAAAAGGAGGGGACCCGCCCACTGCGCCTGCGCG-39
Peri-1 mSp1F 59-AGAAAAAGGAGAAAAAAAAAAAACTGCGCCTGCGCG-39
BPeri-1 ((257)–(222)) 59-BIOTIN-CAACGCCACACGCTCCCGGAAGTAGGAGGCGTCCGA-39
Peri-1 ((257)–(222)) 59-CAACGCCACACGCTCCCTTTAGTAGGAGGCGTCCGA-39
Peri-1 mEts-1 59-CAACGCCACACGCTCCCTTTAGTAGGAGGCGTCCGA-39
BPeri-1 ((288)–(230)) 59- BIOTIN-GGGACCCGCCCACTGCGCCTGCGCGGCGTGACAACGCCACACGCTCCCGGAAGTAGGAG-39
doi:10.1371/journal.pone.0026466.t001
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EMSA, the following procedure was carried out as described
previously [91,92,93,94,95]. Briefly, each aliquot of nuclear
extract was incubated with 1 ml of the antibodies and rocked at
4uC for 1 h in 20 ml of EMSA binding buffer. Ten microlitres of
protein A/G–Agarose beads pre-washed by EMSA binding buffer
were then added and rocked at 4uC for 3 h. The resulting
supernatant was subjected to EMSA analysis.
DNA Affinity Precipitation Assays (DAPAs)
CHO cells were transfected with or without Nc siRNAs. Twelve
hours after transfection, the cell lysates were prepared using the
Cell Lysis Buffer (Beyotime) with PMSF and sonication. The cell
debris was removed by centrifugation (265 min, 10,0006g,4 uC).
The cell extracts, containing 700 mg of protein, were incubated for
16 h with 1 mg of the biotinylated double-stranded oligonucleo-
tides that corresponded to the different regions of the meri-1
promoter, including BPeri-1 ((288)–(230)), BPeri-1 ((299)–
(264)), and BPeri-1((257)–(222)) (see Table 1 for the sequences).
The biotinylated DNA-protein complexes were isolated using the
mMACS
TM Streptavidin Kit (Miltenyi Biotec) according to the
manufacturer’s instructions. The columns were washed five times
and eluted with denaturing buffer. The elutes were then
immunoblotted by Sp1, Ets-1 and STAT3 antibodies, respectively.
Chromatin immunoprecipitation (ChIP) assays
CHO cells were transfected with or without Nc siRNAs. Twelve
hours after transfection, ChIP assays were performed using EZ
ChIP Kit (Upstate, Biotechnology, Lake Placid, NY) and
antibodies against Sp1, Ets-1, STAT3 or control IgG. The input
control DNA or immunoprecipitated DNA was then subjected to
PCR amplification using primers specific to meri-1 promoter (Peri-
1_ChIP_F: 59-CACACGCTCCCGGAAGTAG-39 and Peri-
1_ChIP_R: 59-TCGCTCTCTCCCTTGAAAAA-39). The an-
nealing sites of these primers are shown in Figure 3F. The PCR
products were separated by 2% agarose-gel electrophoresis and
visualized with ethidium bromide staining. Each experiment was
repeated at least three times.
Co-immunoprecipitation (Co-IP)
CHO cells were pre-transfected with the FLAG-Sp1 expression
plasmid and gene specific siRNAs for twelve hours prior to
transfection with Nc siRNA_2. Twelve hours after Nc siRNA_2
transfection, cell lysates were prepared using the Cell Lysis Buffer
containing PMSF and TSA (Cell Signaling Technology, Beverly,
MA) followed by sonication. The cell extracts, containing 1 mg of
protein, were incubated with M2-anti-FLAG antibody-agarose
beads (Sigma) for 3 h. Protein-antibody-agarose complexes were
precipitated, washed, and examined by Western blotting using
indicated antibodies.
Western blots
Antibodies to the Sp1 and Ets-1 nuclear proteins were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
STAT3 antibody was purchased from Cell Signaling Technology
(Beverly, MA). HRP-conjugated FLAG antibody was purchased
from Shanghai Westang Bio-tech Co. Ltd. The transfected cell
lysate was prepared using lysis buffer containing 50 mM Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol, 100 mM dithiothreitol and 0.1%
bromophenol blue. The proteins were resolved on 10% SDS-
PAGE gels and Western blotted using standard protocols. The
primary antibodies were diluted at 1:500 or 1:2000, and the AP- or
HRP-conjugated, goat anti-mouse or goat anti-rabbit secondary
antibody was diluted at 1:2000 before using.
Statistical analyses
Results were expressed as mean 6 SD. Statistical significance
was evaluated for data from three independent experiments using
Student’s t-test. A p value of ,0.05 was considered to be
statistically significant.
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